Zareen Ahmad

Mount Sinai Hospital
Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Improving Systemic Sclerosis Quality of Care.

Improving Systemic Sclerosis Quality of Care.

Journal: The Journal of rheumatology

Published: January 27, 2025

Differences in IgG Sialylation Distinguish Asymptomatic From Symptomatic Antinuclear Antibody-Positive Individuals.

Differences in IgG Sialylation Distinguish Asymptomatic From Symptomatic Antinuclear Antibody-Positive Individuals.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: October 16, 2024

Evaluation of Progression From Preclinical to Systemic Autoimmune Rheumatic Disease: Novel Use of the European Alliance of Associations for Rheumatology/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria as an Outcome Measure.

Evaluation of Progression From Preclinical to Systemic Autoimmune Rheumatic Disease: Novel Use of the European Alliance of Associations for Rheumatology/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria as an Outcome Measure.

Journal: ACR open rheumatology

Published: February 16, 2024

Understanding the Employment Landscape in People With Systemic Sclerosis.

Understanding the Employment Landscape in People With Systemic Sclerosis.

Journal: The Journal of rheumatology

Published: January 30, 2024

Epidemiology and Survival of Systemic Sclerosis-Sarcoidosis Overlap Syndrome.

Epidemiology and Survival of Systemic Sclerosis-Sarcoidosis Overlap Syndrome.

Journal: The Journal of rheumatology

Published: December 31, 2022

Quality Measures in Systemic Sclerosis.

Quality Measures in Systemic Sclerosis.

Journal: Diagnostics (Basel, Switzerland)

Published: December 17, 2022

Advanced Autoantibody Testing in Systemic Sclerosis.

Advanced Autoantibody Testing in Systemic Sclerosis.

Journal: Diagnostics (Basel, Switzerland)

Published: December 13, 2022

Environmental Risks for Systemic Sclerosis.

Environmental Risks for Systemic Sclerosis.

Journal: Rheumatic diseases clinics of North America

Published: November 04, 2022

Altered Balance of Pro-Inflammatory Immune Cells to T Regulatory Cells Differentiates Symptomatic From Asymptomatic Individuals With Anti-Nuclear Antibodies.

Altered Balance of Pro-Inflammatory Immune Cells to T Regulatory Cells Differentiates Symptomatic From Asymptomatic Individuals With Anti-Nuclear Antibodies.

Journal: Frontiers in immunology

Published: February 28, 2022

Interferon and interferon-induced cytokines as markers of impending clinical progression in ANA+ individuals without a systemic autoimmune rheumatic disease diagnosis.

Interferon and interferon-induced cytokines as markers of impending clinical progression in ANA+ individuals without a systemic autoimmune rheumatic disease diagnosis.

Journal: Arthritis research & therapy

Published: February 02, 2022

Botulinum toxin in the management of primary and secondary Raynaud's phenomenon.

Botulinum toxin in the management of primary and secondary Raynaud's phenomenon.

Journal: Best practice & research. Clinical rheumatology

Published: May 09, 2021

Serological abnormalities that predict progression to systemic autoimmune rheumatic diseases in antinuclear antibody-positive individuals.

Serological abnormalities that predict progression to systemic autoimmune rheumatic diseases in antinuclear antibody-positive individuals.

Journal: Rheumatology (Oxford, England)

Published: March 01, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026